Although roFPs are highly sensitive to oxidative stress, their responses can be easily saturated (Fig
Wegovy for weight management) Tirzepatide (Mounjaro), which is a dual GIP/GLP-1 receptor agonist Most of these agents are administered via subcutaneous injection, with dosing frequencies ranging from twice daily to once weekly depending on the specific formulation
For researchers with a history of gallbladder problems, existing gallstones, or other biliary risk factors like rapid previous weight loss episodes or high BMI, this difference should factor into their medication choice
Medical organizations including the American Heart Association and Endocrine Society advise against combining phentermine with semaglutide (Wegovy) due to unpredictable cardiovascular interactions, increased side effects, and lack of clinical evidence supporting safety or added benefit
10.1016/j.arr.2019.100940 Ageing Res